OmniAb (OABI) Interest & Investment Income (2022 - 2026)
OmniAb (OABI) reported Interest & Investment Income of $487000.0 for Q1 2026, down 9.31% year-over-year from $537000.0 in Q1 2025, and down 60.24% quarter-over-quarter from $1.2 million in Q4 2025.
OmniAb (OABI) Interest & Investment Income (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Interest & Investment Income data on file, last reported at $487000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $487000.0, down 9.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 2.17% YoY), and the FY2025 annual result was $2.7 million, down 14.36% from the prior year.
- Interest & Investment Income slipped to $487000.0 in Q1 2026 per OABI's latest filing, from $1.2 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.3 million in Q1 2023 and troughed at $436000.0 in Q2 2025.
- A 5-year average of $849642.9 and a median of $738000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income jumped 101.19% in 2023, then slumped 45.38% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $587000.0 in 2022, then jumped by 101.19% to $1.2 million in 2023, then slumped by 44.54% to $655000.0 in 2024, then surged by 87.02% to $1.2 million in 2025, then tumbled by 60.24% to $487000.0 in 2026.
- Business Quant data shows OABI's Interest & Investment Income at $487000.0 in Q1 2026, $1.2 million in Q4 2025, and $462000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 462,000.00 |
| Jun 30, 2025 | 436,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Dec 31, 2024 | 655,000.00 |
| Sep 30, 2024 | 691,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 587,000.00 |